A team of researchers propose that a population-based study of infective endocarditis in one county in Minnesota provides a unique opportunity to define temporal and seasonal variations in incidence over an extended period.
Researchers analyzed data from patients with a recent diagnosis of IE hospitalized to see whether PCT, proADM, and copeptin have prognostic value in IE compared with CRP, a known biomarker for IE.
![Staphylococcus aureus is a rare cause of myocarditis and typically affects immunocompromised patients with sepsis. S aureus myocarditis usually occurs with endocarditis and may result in the formation of abscesses on the heart valves and muscle.5 “As with viral myocarditis, this disease can present with signs and symptoms of acute myocardial infarction, complicating the diagnosis,” wrote the authors of a 2008 case study.12 “Much of the available data on bacterial myocarditis [were] collected before the development of many modern diagnostic tests and before antibiotics [thus] the appropriate workup, diagnosis and treatment remain unclear.”12 A case report published in 2018 described a 44-year-old man with rheumatoid arthritis taking methotrexate who was diagnosed with S aureus myocarditis (and associated left ventricular apical thrombus) after having septic shock.13 Complete recovery was achieved with a 12-week course of antibiotics and anticoagulation.](https://103luf14i1lu362zph3gadzb-wpengine.netdna-ssl.com/wp-content/uploads/sites/16/2021/03/7staphylococcusaureusgetty1_1479047-507x306.jpg)
Etiologies and characteristics of infective endocarditis in people who inject vs those do not inject drugs were found to significantly differ.
This retrospective study aims to shed light on the relationship between splenic infarction and infection.
Study authors assessed the association between mortality and age, history of cardiac surgery, and other risk factors in patients undergoing surgery for infective endocarditis.
Researchers developed a microsimulation model of the natural history of injection opioid use to assess long-term infective endocarditis mortality associated with injection opioid use in the United States.
A great percentage of patients with pulmonary valve infective endocarditis were found to require surgical management.
A team of investigators reviewed data from institutions within the VA healthcare system to assess the ability of 2 algorithms to identify patients with intravenous drug use-associated infective endocarditis.
The in-hospital mortality for native valve infective endocarditis has decreased between 2002 and 2016.
In parallel to the ongoing national opioid crisis, the incidence rate of infective endocarditis cases has increased markedly among people aged 18 to 29 years with hepatitis C virus infection and those with opioid use disorder.
